Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $161,360 - $199,945
-3,527 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$41.32 - $61.25 $247 - $367
6 Added 0.17%
3,527 $208,000
Q3 2021

Oct 20, 2021

BUY
$39.25 - $50.42 $138,199 - $177,528
3,521 New
3,521 $151,000
Q3 2019

Oct 08, 2019

SELL
$32.49 - $42.13 $161,475 - $209,386
-4,970 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $739 - $830
20 Added 0.4%
4,970 $215,000
Q1 2019

May 06, 2019

BUY
$37.5 - $41.2 $750 - $824
20 Added 0.41%
4,950 $210,000
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $189,657 - $216,229
4,930 New
4,930 $215,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Guidance Point Advisors, LLC Portfolio

Follow Guidance Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guidance Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guidance Point Advisors, LLC with notifications on news.